Thomas Sellig's most recent trade in Achieve Life Sciences Inc. was a trade of 31,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Achieve Life Sciences Inc | Thomas Sellig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Thomas Sellig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 31,500 | 31,500 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Thomas Sellig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 24,000 | 24,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Thomas Sellig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 23,250 | 23,250 | - | - | Stock Option (right to buy) |